Drug delivery for treatment of inner ear disease: Current state of knowledge

Ear and Hearing

Volumn 31, Issue 2, 2010, Pages 156-165

  McCall, Andrew A ^a,b   Swan, Erin E Leary ^c,d   Borenstein, Jeffrey T ^c   Sewell, William F ^a,b   Kujawa, Sharon G ^a,b   McKenna, Michael J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c CHARLES STARK DRAPER LABORATORY   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; NANOPARTICLE;

DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; INNER EAR DISEASE; REVIEW;

ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; GENTAMICINS; HUMANS; HYDROGEL; LABYRINTH DISEASES; NANOPARTICLES;

EID: 77949398782     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e3181c351f2     Document Type: Article

References (109)

1. Abou-Halawa, A. S., & Poe, D. S. (2002). Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol, 23, 494-502.
2. Alzamil, K. S., & Linthicum, F. H., Jr. (2000). Extraneous round window membranes and plugs: Possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol, 109, 30-32.
3. Battista, R. A. (2005). Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 132, 902-905.
4. Batts, S. A., & Raphael, Y. (2007). Transdifferentiation and its applicability for inner ear therapy. Hear Res, 227, 41-47.
5. Beck, C., & Schmidt, C. L. (1978). 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol, 221, 149-152.
6. Behlke, M. A. (2006). Progress towards in vivo use of siRNAs. Mol Ther, 13, 644-670.
7. Berryhill, W. E., & Graham, M. D. (2002). Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am, 35, 675-682.
8. Boleas-Aguirre, M. S., Lin, F. R., Della Santina, C. C., et al. (2008). Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol, 29, 33-38.
9. Borenstein, J. T. (2009). BioMEMS Technologies for Regenerative Medicine. In S. M. Spearing, S. Vengallatore, N. Sheppard, J. Bagdahn (Eds). Micromechanical Systems-Materials and Devices II (Mater Res Soc Symp Proc). Warrendale, PA: Materials Research Society.
10. Borkholder, D. A. (2008). State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg, 16, 472-477.
11. Brookler, K. H., & Tanyeri, H. (1997). Etidronate for the neurotologic symptoms of otosclerosis: Preliminary study. Ear Nose Throat J, 76, 371, 376, 379-381.
12. Brown, J. N., Miller, J. M., Altschuler, R. A., et al. (1993). Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res, 70, 167-172.
13. Chen, Z., Kujawa, S. G., McKenna, M. J., et al. (2005). Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release, 110, 1-19.
14. Chia, S. H., Gamst, A. C., Anderson, J. P., et al. (2004). Intratympanic gentamicin therapy for Meniere's disease: A meta-analysis. Otol Neurotol, 25, 544-552.
15. Chrousos, G. P. (2007). Adrenocorticosteroids and Adrenocortical Antagonists. In B. G. Katzung (Ed). Basic and Clinical Pharmacology (pp, 635- 652). New York: McGraw-Hill.
16. Chung, A. J., Kim, D., Erickson, D. (2008). Electrokinetic microfluidic devices for rapid, low power drug delivery in autonomous microsystems. Lab Chip, 8, 330-338.
17. Coelho, D. H., & Lalwani, A. K. (2008). Medical management of Meniere's disease. Laryngoscope, 118, 1099-1108.
18. Conlin, A. E., & Parnes, L. S. (2007). Treatment of sudden sensorineural hearing loss. I. A systematic review. Arch Otolaryngol Head Neck Surg, 133, 573-581.
19. Corrales, C. E., Pan, L., Li, H., et al. (2006). Engraftment and differentiation of embryonic stem cell-derived neural progenitor cells in the cochlear nerve trunk: Growth of processes into the organ of Corti. J Neurobiol, 66, 1489-1500.
20. Dinh, C., Hoang, K., Haake, S., et al. (2008). Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: Implications toward the development of a drug-eluting cochlear implant electrode array. Otol Neurotol, 29, 1012-1019.
21. Eddington, D. T., & Beebe, D. J. (2004). A valved responsive hydrogel microdispensing device with integrated pressure source. J Microelectromech Syst, 13, 586-593.
22. Endo, T., Nakagawa, T., Kita, T., et al. (2005). Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope, 115, 2016-2020.
23. Eshraghi, A. A., Adil, E., He, J., et al. (2007). Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol, 28, 842-849.
24. Fayad, J. N., & Linthicum, F. H., Jr. (2006). Multichannel cochlear implants: Relation of histopathology to performance. Laryngoscope, 116, 1310-1320.
25. Fiering, J., Mescher, M. J., Leary Swan, E. E., et al. (2008). Local drug delivery with a self-contained, programmable, microfluidic system. Biomed Microdevices, 11, 571-578.
26. Fowler, E. P., Jr. (1948). Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol, 52, 293-301.
27. Gantz, B. J., Turner, C., Gfeller, K. E. (2006). Acoustic plus electric speech processing: Preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant. Audiol Neurootol, 11(Suppl. 1), 63-68.
28. Gantz, B. J., & Turner, C. W. (2003). Combining acoustic and electrical hearing. Laryngoscope, 113, 1726-1730.
29. Garduno-Anaya, M. A., Couthino De Toledo, H., Hinojosa-Gonzalez, R., et al. (2005). Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: A two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg, 133, 285-294.
30. Ge, X., Jackson, R. L., Liu, J., et al. (2007). Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol Head Neck Surg, 137, 619-623.
31. Gillespie, L. N., Clark, G. M., Bartlett, P. F., et al. (2001). LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport, 12, 275-279.
32. Graham, M. D., & Kemink, J. L. (1984). Titration streptomycin therapy for bilateral Meniere's disease: A progress report. Am J Otol, 5, 534-535.
33. Harner, S. G., Driscoll, C. L., Facer, G. W., et al. (2001). Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol, 22, 210-214.
34. Haynes, D. S., O'Malley, M., Cohen, S., et al. (2007). Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope, 117, 3-15.
35. Hendricks, J. L., Chikar, J. A., Crumling, M. A., et al. (2008). Localized cell and drug delivery for auditory prostheses. Hear Res, 242, 117-131.
36. Hildebrand, M. S., Newton, S. S., Gubbels, S. P., et al. (2008). Advances in molecular and cellular therapies for hearing loss. Mol Ther, 16, 224-236.
37. Hill, S. L., III, Digges, E. N., Silverstein, H. (2006). Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere's disease. Ear Nose Throat J, 85, 494, 496, 498.
38. Hochman, J., Blakley, B., Abdoh, A., et al. (2006). Post-tympanostomy tube otorrhea: A meta-analysis. Otolaryngol Head Neck Surg, 135, 8-11.
39. Hoffer, M. E., Allen, K., Kopke, R. D., et al. (2001). Transtympanic versus sustained-release administration of gentamicin: Kinetics, morphology, and function. Laryngoscope, 111, 1343-1357.
40. Hornyak, G. L. (2005). Nanotechnology in otolaryngology. Otolaryngol Clin North Am, 38, 273-293, vi.
41. Huang, C. Q., Tykocinski, M., Stathopoulos, D., et al. (2007). Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants Int, 8, 123-147.
42. Incesulu, A., & Nadol, J. B., Jr. (1998). Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: Implications for cochlear implantation. Ann Otol Rhinol Laryngol, 107, 906-911.
43. Ito, J., Kojima, K., Kawaguchi, S. (2001). Survival of neural stem cells in the cochlea. Acta Otolaryngol, 121, 140-142.
44. Itoh, A., & Sakata, E. (1991). Treatment of vestibular disorders. Acta Otolaryngol Suppl, 481, 617-623.
45. Izumikawa, M., Minoda, R., Kawamoto, K., et al. (2005). Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med, 11, 271-276.
46. James, C. J., Fraysse, B., Deguine, O., et al. (2006). Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol Neurootol, 11(Suppl. 1), 57-62.
47. James, D. P., Eastwood, H., Richardson, R. T., et al. (2008). Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol, 13, 86-96.
48. Kennedy, D. W., Hoffer, M. E., Holliday, M. (1993). The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg, 109, 461-467.
49. Khan, A. M., Handzel, O., Burgess, B. J., et al. (2005). Is word recognition correlated with the number of surviving spiral ganglion cells and electrode insertion depth in human subjects with cochlear implants? Laryngoscope, 115, 672-677.
50. Kiefer, J., Pok, M., Adunka, O., et al. (2005). Combined electric and acoustic stimulation of the auditory system: Results of a clinical study. Audiol Neurootol, 10, 134-144.
51. Kingma, G. G., Miller, J. M., Myers, M. W. (1992). Chronic drug infusion into the scala tympani of the guinea pig cochlea. J Neurosci Methods, 45, 127-134.
52. Kopke, R. D., Wassel, R. A., Mondalek, F., et al. (2006). Magnetic nanoparticles: Inner ear targeted molecule delivery and middle ear implant. Audiol Neurootol, 11, 123-133.
53. Kujawa, S. G., & Sewell, W.F. (2006). From Pharmacology to Function: Using Drugs as Tools to Dissect the Cochlea. In K. C. M. Campbell (Ed). Pharmacology and Ototoxicity for Audiologists (pp, 320-340). New York: Delmar.
54. Lange, G. (1977). [The intratympanic treatment of Meniere's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)]. Laryngol Rhinol Otol (Stuttg), 56, 409-414.
55. Lautermann, J., Sudhoff, H., Junker, R. (2005). Transtympanic corticoid therapy for acute profound hearing loss. Eur Arch Otorhinolaryngol, 262, 587-591.
56. Lee, K. Y., Nakagawa, T., Okano, T., et al. (2007). Novel therapy for hearing loss: Delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol Neurotol, 28, 976-981.
57. Lefebvre, P. P., Staecker, H. (2002). Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: A pilot study. Acta Otolaryngol, 122, 698-702.
58. Li, H., Liu, H., Heller, S. (2003). Pluripotent stem cells from the adult mouse inner ear. Nat Med, 9, 1293-1299.
59. Licameli, G., Johnston, P., Luz, J., et al. (2008). Phosphorylcholine- coated antibiotic tympanostomy tubes: Are post-tube placement complications reduced? Int J Pediatr Otorhinolaryngol, 72, 1323-1328.
60. Light, J. P., & Silverstein, H. (2004). Transtympanic perfusion: Indications and limitations. Curr Opin Otolaryngol Head Neck Surg, 12, 378-383.
61. Maeda, Y., Fukushima, K., Nishizaki, K., et al. (2005). In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet, 14, 1641-1650.
62. Malgrange, B., Lefebvre, P. P., Martin, D., et al. (1996). NT-3 has a tropic effect on process outgrowth by postnatal auditory neurones in vitro. Neuroreport, 7, 2495-2499.
63. Martinez-Monedero, R., Oshima, K., Heller, S., et al. (2007). The potential role of endogenous stem cells in regeneration of the inner ear. Hear Res, 227, 48-52.
64. McAllister, D. V., Wang, P. M., Davis, S. P., et al. (2003). Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA, 100, 13755-13760.
65. Miller, J. M., Le Prell, C. G., Prieskorn, D. M., et al. (2007). Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: Effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res, 85, 1959-1969.
66. Minor, L. B. (1999). Intratympanic gentamicin for control of vertigo in Meniere's disease: Vestibular signs that specify completion of therapy. Am J Otol, 20, 209-219.
67. Mukherjea, D., Jajoo, S., Whitworth, C., et al. (2008). Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatininduced hearing loss in the rat. J Neurosci, 28, 13056-13065.
68. Nakagawa, T., & Ito, J. (2007). Drug delivery systems for the treatment of sensorineural hearing loss. Acta Otolaryngol Suppl, 557, 30-35.
69. NIDCD. (2003). Sudden Deafness. Retrieved November 3, 2008 from http://www.nidcd.nih.gov/health/hearing/sudden.asp.
70. NIDCD. (2008). Statistics About Hearing Disorders, Ear Infections, and Deafness. Retrieved October 18, 2008 from www.nidcd.nih.gov/health/ statistics/quick.htm.
71. Oshima, K., Grimm, C. M., Corrales, C. E., et al. (2007). Differential distribution of stem cells in the auditory and vestibular organs of the inner ear. J Assoc Res Otolaryngol, 8, 18-31.
72. Paasche, G., Bogel, L., Leinung, M., et al. (2006). Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes. Hear Res, 212, 74-82.
73. Paulson, D. P., Abuzeid, W., Jiang, H., et al. (2008). A novel controlled local drug delivery system for inner ear disease. Laryngoscope, 118, 706-711.
74. Plontke, S., Lowenheim, H., Preyer, S., et al. (2005). Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: Basis for planning randomized controlled trials. Acta Otolaryngol, 125, 830-839.
75. Plontke, S. K., Zimmermann, R., Zenner, H. P., et al. (2006). Technical note on microcatheter implantation for local inner ear drug delivery: Surgical technique and safety aspects. Otol Neurotol, 27, 912-917.
76. Praetorius, M., Brunner, C., Lehnert, B., et al. (2007). Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol, 127, 486-490.
77. Prescott, J. H., Lipka, S., Baldwin, S., et al. (2006). Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol, 24, 437-438.
78. Prieskorn, D. M., & Miller, J. M. (2000). Technical report: Chronic and acute intracochlear infusion in rodents. Hear Res, 140, 212-215.
79. Rauch, S. D. (2008). Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med, 359, 833-840.
80. Richardson, R. T., Wise, A. K., Thompson, B. C., et al. (2009). Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials, 30, 2614-2624.
81. Sajjadi, H., & Paparella, M. M. (2008). Meniere's disease. Lancet, 372, 406-414.
82. Salt, A. N. (2005). Pharmacokinetics of drug entry into cochlear fluids. Volta Rev, 105, 277-298.
83. Salt, A. N., & Plontke, S. K. (2005). Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today, 10, 1299-1306.
84. Sataloff, R. T., McCarter, A., Spiegel, J. R. (1996). Very high-dose streptomycin labyrinthectomy. Ear Nose Throat J, 75, 239-243.
85. Schuknecht, H. F. (1956). Ablation therapy for the relief of Meniere's disease. Laryngoscope, 66, 859-870.
86. Sewell, W. F., Borenstein, J. T., Chen, Z., et al. (2009). Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurotol, 14, 411-422.
87. Shi, F., Corrales, C. E., Liberman, M. C., et al. (2007). BMP4 induction of sensory neurons from human embryonic stem cells and reinnervation of sensory epithelium. Eur J Neurosci, 26, 3016-3023.
88. Silverstein, H., Isaacson, J. E., Olds, M. J., et al. (1998). Dexamethasone inner ear perfusion for the treatment of Meniere's disease: A prospective, randomized, double-blind, crossover trial. Am J Otol, 19, 196-201.
89. Silverstein, H., Jackson, L. E., Rosenberg, S. I. (2001). Silverstein Microwick(TM) for treatment of inner ear disease. Oper Tech Otolaryngol Head Neck Surg, 12, 144-147.
90. Silverstein, H., Rowan, P. T., Olds, M. J., et al. (1997). Inner ear perfusion and the role of round window patency. Am J Otol, 18, 586-589.
91. Slattery, W. H., Fisher, L. M., Iqbal, Z., et al. (2005). Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg, 133, 251-259.
92. Stokroos, R. J., Albers, F. W., Tenvergert, E. M. (1998). Antiviral treatment of idiopathic sudden sensorineural hearing loss: A prospective, randomized, double-blind clinical trial. Acta Otolaryngol, 118, 488-495.
93. Tamura, T., Kita, T., Nakagawa, T., et al. (2005). Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope, 115, 2000-2005.
94. Tao, S. L., & Desai, T. A. (2005). Microfabrication of multilayer, asymmetric, polymeric devices for drug delivery. Adv Mater, 17, 1625-1630.
95. Tucci, D. L., Farmer, J. C., Jr., Kitch, R. D., et al. (2002). Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol, 23, 301-308.
96. Turner, C. W., Reiss, L. A., Gantz, B. J. (2008). Combined acoustic and electric hearing: Preserving residual acoustic hearing. Hear Res, 242, 164-171.
97. Uri, N., Doweck, I., Cohen-Kerem, R., et al. (2003). Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 128, 544-549.
98. Van Wijck, F., Staecker, H., Lefebvre, P. P. (2007). Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol, 127, 1012-1017.
99. Vivero, R. J., Joseph, D. E., Angeli, S., et al. (2008). Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope, 118, 2028-2035.
100. Wang, Z., Jiang, H., Yan, Y., et al. (2006). Characterization of proliferating cells from newborn mouse cochleae. Neuroreport, 17, 767-771.
101. Warnecke, A., Wissel, K., Hoffmann, A., et al. (2007). The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport, 18, 1683-1686.
102. Wei, B. P., Mubiru, S., O'Leary, S. (2006). Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, CD003998.
103. Wei, D., Levic, S., Nie, L., et al. (2008). Cells of adult brain germinal zone have properties akin to hair cells and can be used to replace inner ear sensory cells after damage. Proc Natl Acad Sci USA, 105, 21000-21005.
104. Westerlaken, B. O., Stokroos, R. J., Dhooge, I. J., et al. (2003). Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: A prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol, 112, 993-1000.
105. Wilson, W. R., Byl, F. M., Laird, N. (1980). The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol, 106, 772-776.
106. Ye, Q., Tillein, J., Hartmann, R., et al. (2007). Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear, 28, 361-369.
107. Youssef, T. F., & Poe, D. S. (1998). Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol, 19, 435-442.
108. Zhang, Y., Zhai, S. Q., Shou, J., et al. (2007). Isolation, growth and differentiation of hair cell progenitors from the newborn rat cochlear greater epithelial ridge. J Neurosci Methods, 164, 271-279.
109. Zou, J., Saulnier, P., Perrier, T., et al. (2008). Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J Biomed Mater Res B Appl Biomater, 87, 10-18.